MAPT and Alzheimer disease: Longitudinal and cross-sectional multi-target and multi-modality studies are encouraged to further elucidate the role of tau in the course of AD, as well as its interaction and relationship with Aβ deposition, synaptic dysfunction, brain atrophy, and other pathological biomarkers.